Trends and predictors of changes in pulmonary function after treatment for pulmonary tuberculosis

Kuei Pin Chung, Jung Yueh Chen, Chih Hsin Lee, Huey Dong Wu, Jann Yuan Wang, Li Na Lee, Chong Jen Yu, Pan Chyr Yang

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

OBJECTIVES: The present study aimed to investigate the trends in changes in pulmonary function and the risk factors for pulmonary function deterioration in patients with pulmonary tuberculosis after completing treatment. INTRODUCTION: Patients usually have pulmonary function abnormalities after completing treatment for pulmonary tuberculosis. The time course for changes in pulmonary function and the risk factors for deterioration have not been well studied. METHODS: A total of 115 patients with 162 pulmonary function results were analyzed. We retrieved demographic and clinical data, radiographic scores, bacteriological data, and pulmonary function data. A generalized additive model with a locally weighted scatterplot smoothing technique was used to evaluate the trends in changes in pulmonary function. A generalized estimating equation model was used to determine the risk factors associated with deterioration of pulmonary function. RESULTS: The median interval between the end of anti-tuberculosis treatment and the pulmonary function test was 16 months (range: 0 to 112 months). The nadir of pulmonary function occurred approximately 18 months after the completion of the treatment. The risk factors associated with pulmonary function deterioration included smearpositive disease, extensive pulmonary involvement prior to anti-tuberculosis treatment, prolonged anti-tuberculosis treatment, and reduced radiographic improvement after treatment. CONCLUSIONS: After the completion of anti-tuberculosis TB treatment, several risk factors predicted pulmonary function deterioration. For patients with significant respiratory symptoms and multiple risk factors, the pulmonary function test should be followed up to monitor the progression of functional impairment, especially within the first 18 months after the completion of anti-tuberculosis treatment.

Original languageEnglish
Pages (from-to)549-556
Number of pages8
JournalClinics
Volume66
Issue number4
DOIs
Publication statusPublished - 2011
Externally publishedYes

Fingerprint

Pulmonary Tuberculosis
Lung
Tuberculosis
Therapeutics
Respiratory Function Tests
Lung Diseases
Demography

Keywords

  • Completion of treatment
  • Disease extent
  • Pulmonary function
  • Pulmonary tuberculosis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Trends and predictors of changes in pulmonary function after treatment for pulmonary tuberculosis. / Chung, Kuei Pin; Chen, Jung Yueh; Lee, Chih Hsin; Wu, Huey Dong; Wang, Jann Yuan; Lee, Li Na; Yu, Chong Jen; Yang, Pan Chyr.

In: Clinics, Vol. 66, No. 4, 2011, p. 549-556.

Research output: Contribution to journalArticle

Chung, KP, Chen, JY, Lee, CH, Wu, HD, Wang, JY, Lee, LN, Yu, CJ & Yang, PC 2011, 'Trends and predictors of changes in pulmonary function after treatment for pulmonary tuberculosis', Clinics, vol. 66, no. 4, pp. 549-556. https://doi.org/10.1590/S1807-59322011000400005
Chung, Kuei Pin ; Chen, Jung Yueh ; Lee, Chih Hsin ; Wu, Huey Dong ; Wang, Jann Yuan ; Lee, Li Na ; Yu, Chong Jen ; Yang, Pan Chyr. / Trends and predictors of changes in pulmonary function after treatment for pulmonary tuberculosis. In: Clinics. 2011 ; Vol. 66, No. 4. pp. 549-556.
@article{f5173600f26642d2ba743f4808927d52,
title = "Trends and predictors of changes in pulmonary function after treatment for pulmonary tuberculosis",
abstract = "OBJECTIVES: The present study aimed to investigate the trends in changes in pulmonary function and the risk factors for pulmonary function deterioration in patients with pulmonary tuberculosis after completing treatment. INTRODUCTION: Patients usually have pulmonary function abnormalities after completing treatment for pulmonary tuberculosis. The time course for changes in pulmonary function and the risk factors for deterioration have not been well studied. METHODS: A total of 115 patients with 162 pulmonary function results were analyzed. We retrieved demographic and clinical data, radiographic scores, bacteriological data, and pulmonary function data. A generalized additive model with a locally weighted scatterplot smoothing technique was used to evaluate the trends in changes in pulmonary function. A generalized estimating equation model was used to determine the risk factors associated with deterioration of pulmonary function. RESULTS: The median interval between the end of anti-tuberculosis treatment and the pulmonary function test was 16 months (range: 0 to 112 months). The nadir of pulmonary function occurred approximately 18 months after the completion of the treatment. The risk factors associated with pulmonary function deterioration included smearpositive disease, extensive pulmonary involvement prior to anti-tuberculosis treatment, prolonged anti-tuberculosis treatment, and reduced radiographic improvement after treatment. CONCLUSIONS: After the completion of anti-tuberculosis TB treatment, several risk factors predicted pulmonary function deterioration. For patients with significant respiratory symptoms and multiple risk factors, the pulmonary function test should be followed up to monitor the progression of functional impairment, especially within the first 18 months after the completion of anti-tuberculosis treatment.",
keywords = "Completion of treatment, Disease extent, Pulmonary function, Pulmonary tuberculosis",
author = "Chung, {Kuei Pin} and Chen, {Jung Yueh} and Lee, {Chih Hsin} and Wu, {Huey Dong} and Wang, {Jann Yuan} and Lee, {Li Na} and Yu, {Chong Jen} and Yang, {Pan Chyr}",
year = "2011",
doi = "10.1590/S1807-59322011000400005",
language = "English",
volume = "66",
pages = "549--556",
journal = "Clinics",
issn = "1807-5932",
publisher = "University of Sao Paolo",
number = "4",

}

TY - JOUR

T1 - Trends and predictors of changes in pulmonary function after treatment for pulmonary tuberculosis

AU - Chung, Kuei Pin

AU - Chen, Jung Yueh

AU - Lee, Chih Hsin

AU - Wu, Huey Dong

AU - Wang, Jann Yuan

AU - Lee, Li Na

AU - Yu, Chong Jen

AU - Yang, Pan Chyr

PY - 2011

Y1 - 2011

N2 - OBJECTIVES: The present study aimed to investigate the trends in changes in pulmonary function and the risk factors for pulmonary function deterioration in patients with pulmonary tuberculosis after completing treatment. INTRODUCTION: Patients usually have pulmonary function abnormalities after completing treatment for pulmonary tuberculosis. The time course for changes in pulmonary function and the risk factors for deterioration have not been well studied. METHODS: A total of 115 patients with 162 pulmonary function results were analyzed. We retrieved demographic and clinical data, radiographic scores, bacteriological data, and pulmonary function data. A generalized additive model with a locally weighted scatterplot smoothing technique was used to evaluate the trends in changes in pulmonary function. A generalized estimating equation model was used to determine the risk factors associated with deterioration of pulmonary function. RESULTS: The median interval between the end of anti-tuberculosis treatment and the pulmonary function test was 16 months (range: 0 to 112 months). The nadir of pulmonary function occurred approximately 18 months after the completion of the treatment. The risk factors associated with pulmonary function deterioration included smearpositive disease, extensive pulmonary involvement prior to anti-tuberculosis treatment, prolonged anti-tuberculosis treatment, and reduced radiographic improvement after treatment. CONCLUSIONS: After the completion of anti-tuberculosis TB treatment, several risk factors predicted pulmonary function deterioration. For patients with significant respiratory symptoms and multiple risk factors, the pulmonary function test should be followed up to monitor the progression of functional impairment, especially within the first 18 months after the completion of anti-tuberculosis treatment.

AB - OBJECTIVES: The present study aimed to investigate the trends in changes in pulmonary function and the risk factors for pulmonary function deterioration in patients with pulmonary tuberculosis after completing treatment. INTRODUCTION: Patients usually have pulmonary function abnormalities after completing treatment for pulmonary tuberculosis. The time course for changes in pulmonary function and the risk factors for deterioration have not been well studied. METHODS: A total of 115 patients with 162 pulmonary function results were analyzed. We retrieved demographic and clinical data, radiographic scores, bacteriological data, and pulmonary function data. A generalized additive model with a locally weighted scatterplot smoothing technique was used to evaluate the trends in changes in pulmonary function. A generalized estimating equation model was used to determine the risk factors associated with deterioration of pulmonary function. RESULTS: The median interval between the end of anti-tuberculosis treatment and the pulmonary function test was 16 months (range: 0 to 112 months). The nadir of pulmonary function occurred approximately 18 months after the completion of the treatment. The risk factors associated with pulmonary function deterioration included smearpositive disease, extensive pulmonary involvement prior to anti-tuberculosis treatment, prolonged anti-tuberculosis treatment, and reduced radiographic improvement after treatment. CONCLUSIONS: After the completion of anti-tuberculosis TB treatment, several risk factors predicted pulmonary function deterioration. For patients with significant respiratory symptoms and multiple risk factors, the pulmonary function test should be followed up to monitor the progression of functional impairment, especially within the first 18 months after the completion of anti-tuberculosis treatment.

KW - Completion of treatment

KW - Disease extent

KW - Pulmonary function

KW - Pulmonary tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=79958704147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958704147&partnerID=8YFLogxK

U2 - 10.1590/S1807-59322011000400005

DO - 10.1590/S1807-59322011000400005

M3 - Article

C2 - 21655745

AN - SCOPUS:79958704147

VL - 66

SP - 549

EP - 556

JO - Clinics

JF - Clinics

SN - 1807-5932

IS - 4

ER -